You are here: Home » 2022 » Archives for June 2022

IRNT TUESDAY DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages IronNet, Inc. Investors With Losses to Secure Counsel Before Important June 21 Deadline in Securities Class Action – IRNT

NEW YORK, June 15, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of IronNet, Inc. (NYSE: IRNT) between September 15, 2021 and December 15, 2021, inclusive (the "Class Period"), of the important June 21, 2022 lead plaintiff deadline.

SO WHAT: If you purchased IronNet securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the IronNet class action, go to https://rosenlegal.com/submit–form/?case_id=5641 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 21, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) IronNet had materially overstated its business and financial prospects; (2) IronNet was unable to predict the timing of significant customer opportunities which constituted a substantial portion of its publicly–issued FY 2022 financial guidance; (3) IronNet had not established effective disclosure controls and procedures to reasonably ensure its public disclosures were timely, accurate, complete, and not otherwise misleading; and (4) as a result, defendants' public statements were materially false, misleading, and/or lacked any reasonable basis in fact at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the IronNet class action, go to https://rosenlegal.com/submit–form/?case_id=5641 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8572900)

McKinsey & Company’s new research shows the metaverse could grow up to $5 trillion in value by 2030

NEW YORK and LONDON and PARIS, June 15, 2022 (GLOBE NEWSWIRE) — McKinsey & Company released its new report "Value creation in the metaverse," which shows the metaverse may be too big to ignore. McKinsey's preliminary forecast shows the metaverse has the potential to grow up to $5 trillion in value by 2030. It shows e–commerce as the largest economic force ($2.6 trillion), ahead of sectors such as virtual learning ($270 billion), advertising ($206 billion), and gaming ($125 billion).

As companies of all different shapes and sizes look to enter the metaverse, this extensive report provides a clear view of what the metaverse is and is not, what first movers are doing, what's fueling the investment, and the potential for consumer and B2B companies.

The report builds on multiple proprietary insights and analysis, including a survey of more than 3,400 consumers and executives on adoption of the metaverse, its potential, and its likely impact on behavior. The researchers also interviewed metaverse builders and industry experts.

"The metaverse represents a strategic inflection point for companies, and it presents a significant opportunity to influence the way we live, connect, learn, innovate, and collaborate," said Eric Hazan, senior partner, McKinsey & Company. "Our ambition is to help leaders of both consumer and B2B companies better understand its power and potential, identify strategic imperatives, and act as a force for its evolution."

What's fueling the metaverse investment
Already this year, companies, venture capital, and private equity firms have invested more than $120 billion in the metaverse""more than double the $57 billion invested in all of last year.

Multiple factors are driving this investor enthusiasm:

  • ongoing technological advances across the infrastructure required to power the metaverse
  • demographic tailwinds
  • increasingly consumer–led brand marketing and engagement
  • increasing marketplace readiness as users explore today's version of the metaverse, which is largely driven by gaming while applications emerge in socializing, fitness, commerce, virtual learning, and other uses

Already, more than three billion gamers worldwide have access to different versions of the metaverse.

"While the idea of connecting virtually has been decades in the making, it is now increasingly real, meaning real people are using it and spending real money and companies are betting big," said Lareina Yee, senior partner, McKinsey & Company. "Yet this booming interest has made it difficult to separate hype from reality. It's worth remembering that while the bust of the first dot–com boom resulted in the disappearance of scores of companies, the internet itself went from strength to strength, giving rise to new entrants."

Consumers are already engaging in the metaverse
Consumers are already there. McKinsey's research shows consumers are excited about transitioning life into the metaverse, with almost six in ten (59%) consumers preferring at least one metaverse experience over its physical alternative.

Among those consumers, certain types of activities stand out for being most preferred in the immersive world:

  • shopping""purchasing physical or virtual goods (79%)
  • attending virtual social events or playing social games (78%)
  • exercising using virtual reality (76%)

Senior leaders believe the metaverse will have a significant impact on their industry
Business leaders see the metaverse's potential to drive impact and margin growth. Ninety–five percent of leaders say they expect the metaverse to have a positive impact on their industry within five to ten years, with 31 percent saying the metaverse will fundamentally change the way their industry operates. More significantly, a quarter of leaders expect the metaverse technology to drive more than 15 percent of their organization's total margin growth in the next five years.

"The metaverse has put us at the cusp of the next wave of digital disruption," said Tarek Elmasry, senior partner, McKinsey & Company. "It's transformative. It will likely have a major impact on our commercial and personal lives, which is why businesses, policy makers, consumers, and citizens may want to explore and understand as much as they can about this phenomenon, the technology that will underpin it, and the ramifications it could have for our economies and wider society."

For more insights and to read the full report, please click here.

About the report
McKinsey surveyed more than 3,400 consumers and senior executives across Asia""Pacific, China, Europe, and the United States to gain insight into the habits of current metaverse users""their motivations, what they are doing, and what they expect to do. In analyzing the metaverse's value–creation potential and total investment landscape, we examined the drivers of activity among major corporations, venture capital, and private–equity funds. We examined the potential impact of the metaverse on sectors most closely tied to its technology and uses, supplementing our work with additional research, case studies, and real–world examples. The report also includes an in–depth analysis of five industries: apparel, fashion, and luxury; consumer packaged goods; financial services; retail; and telecommunications, media, and technology.

About McKinsey & Company
McKinsey & Company is a global management consulting firm committed to helping organizations realize sustainable, inclusive growth. We work with clients across the private, public, and social sectors to solve complex problems and create positive change for all their stakeholders. We combine bold strategies and transformative technologies to help organizations innovate more sustainably, achieve lasting gains in performance, and build workforces that will thrive for in this generation and the next.

About Growth, Marketing & Sales, McKinsey & Company
The mission of McKinsey's Growth, Marketing & Sales Practice is to help leaders of both consumer and business–to–business clients create Growth That Matters through meaningful transformations and marketing–driven profit. The practice helps its clients set their strategic direction, develop their marketing and sales capabilities, and connect their organization to realize the full potential of today's omnichannel opportunities. Clients benefit from McKinsey's experience in core areas of growth, marketing and sales such as growth strategy, branding, customer insights, marketing ROI, digital marketing, CLM, pricing, and sales and channel management.

For more information, please contact
US media contact: MaryLiz Ghanem, DiGennaro Communications, McKinsey–DiGennaro@digennaro–usa.com, +1 917 518 8422

UK media contact: Ruth Jones, 3THINKRS, mckinsey@3thinkrs.com, +44 0208 0872843


GLOBENEWSWIRE (Distribution ID 8572271)

Kyocera Document Solutions Inc. Selects Anaqua for Integrated IP Management

BOSTON, June 14, 2022 (GLOBE NEWSWIRE) — Anaqua, the leading provider of innovation and intellectual property management solutions, today announced that global document solutions provider Kyocera Document Solutions Inc. has selected Anaqua's AQX platform for integrated management of the company's extensive patent portfolio.

Headquartered in Osaka, Japan, Kyocera Document Solutions Inc. provides customers worldwide with a range of products, business applications, and consultative services to optimize and manage their document workflow, greatly enhancing operational efficiency.

Kyocera Document Solutions Inc. chose Anaqua's AQX Corporate platform as its primary patent management system with patent annuity payments from Anaqua Services fully integrated to unify patent management and payment management. Through this integrated functionality of the AQX Corporate platform and the availability of detailed, up–to–the–minute data visualization dashboards, Kyocera Document Solutions Inc. will be able to better manage, maintain and optimize the value of its portfolio.

"We were looking for an integrated approach that would enable us to manage our patent portfolio more efficiently and holistically," said General Manager of Legal and Intellectual Property Division, Seitaro Yoshida of Kyocera Document Solutions Inc. "AQX's comprehensive intellectual property management platform enabled global IP management for us. During implementation, Anaqua and Kyocera Document Solutions Inc. worked closely together to build up a new workflow. Anaqua listened and were responsive to our needs, enabling us to achieve the best fit for our operations."

"We are delighted to have been selected by Kyocera Document Solutions Inc. to help them manage their IP as the company continues in its goal of helping other organizations around the world put knowledge to work to drive change," said Bob Romeo, CEO of Anaqua. "The agreement not only reflects our strength in the business solutions sector, but also our increasing role in the Japanese market, where more and more companies are entrusting Anaqua with their IP management."

About Anaqua
Anaqua, Inc. is a premium provider of integrated intellectual property (IP) management technology solutions and services for corporations and law firms. Its IP management software solutions, AQX and PATTSY WAVE, both offer best practice workflows with big data analytics and tech–enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision–making, and streamline IP operations, tailored to each segment's need. Today, nearly half of the top 100 U.S. patent filers and global brands, as well as a growing number of law firms worldwide use Anaqua's solutions. Over one million IP executives, attorneys, paralegals, administrators, and innovators use the platform for their IP management needs. The company's global operations are headquartered in Boston, with offices across the U.S., Europe, and Asia. For additional information, please visit anaqua.com, or on LinkedIn.

About Kyocera Document Solutions Inc.
Kyocera Document Solutions Inc. is a global leading provider of total document solutions based in Osaka, Japan. The company's portfolio includes reliable and eco–friendly MFPs and printers, as well as business applications and consultative services which enable customers to optimize and manage their document workflow, reaching new heights of efficiency. With professional expertise and a culture of empathetic partnership, the objective of the company is to help organisations put knowledge to work to drive change.

Kyocera Document Solutions Inc. is a group company of Kyocera Corporation (Kyocera), a leading supplier of semiconductor packages, industrial and automotive components, semiconductor packages, electronic devices, smart energy systems, printers, copiers, and mobile phones. During the year ended March 31, 2022, the Kyocera Group's consolidated sales revenue totaled 1.8 trillion yen (approx. US$15.1 billion). Kyocera is ranked #665 on Forbes magazine's 2022 "Global 2000" list of the world's largest publicly traded companies, and has been named by The Wall Street Journal among "The World's 100 Most Sustainably Managed Companies."

Company Contact:
Amanda Hollis
Communications Director
Anaqua
617–375–2626
ahollis@Anaqua.com


GLOBENEWSWIRE (Distribution ID 8572220)

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Riskified Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 1 Deadline in Securities Class Action – RSKD

NEW YORK, June 14, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Riskified Ltd. (NYSE: RSKD) pursuant and/or traceable to the Registration Statement issued in connection with the Company's initial public offering conducted on or about July 28, 2021 (the "IPO" or "Offering"), of the important July 1, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Riskified securities pursuant and/or traceable to the IPO you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Riskified class action, go to https://rosenlegal.com/submit–form/?case_id=5896 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 1, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the IPO Registration Statement was negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation. Specifically, the IPO Registration Statement made inaccurate statements of material fact because they failed to disclose the following adverse facts that existed at the time of the IPO: (1) as Riskified expanded its user base, the quality of Riskified's machine learning platform had deteriorated (rather than improved as represented in the Registration Statement), because of, among other things, inaccuracies in the algorithms associated with onboarding new merchants and entering new geographies and industries; (2) Riskified had expanded its customer base into industries with relatively high rates of fraud "" including partnerships with cryptocurrency and remittance business "" in which Riskified had limited experience and that this expansion has negatively impacted the effectiveness of Riskified's machine learning platform; (3) as a result, Riskified was suffering from materially higher chargebacks and cost of revenue and depressed gross profits and gross profit margins during its third fiscal quarter of 2021; and (4) thus, the Registration Statement's representations regarding Riskified's historical financial and operational metrics and purported market opportunities did not accurately reflect the actual business, operations, and financial results and trajectory of Riskified prior to and at the time of the IPO, and were materially false and misleading, and lacked a factual basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Riskified class action, go to https://rosenlegal.com/submit–form/?case_id=5896 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8572322)

ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Pegasystems Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – PEGA

NEW YORK, June 14, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Pegasystems Inc. (NASDAQ: PEGA) between May 29, 2020 and May 9, 2022, both dates inclusive (the "Class Period"), of the important July 18, 2022 lead plaintiff deadline.

SO WHAT: If you purchased PEGA securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the PEGA class action, go to https://rosenlegal.com/submit–form/?case_id=6286 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 18, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) PEGA had engaged in corporate espionage and misappropriation of trade secrets to better compete against Appian; (2) Defendants' product development and associated success was, in significant part, not the result of its own research and product testing but rather the result of such corporate espionage and trade secret theft; (3) Defendants had engaged in a scheme to steal Appian trade secrets, which was not only known to, but carried out through the personal involvement of PEGA's CEO; (4) PEGA's CEO and other officers and employees did not comply with PEGA's written Code of Conduct; (5) PEGA was "unable to reasonably estimate damages" in the Appian Litigation; and (6) as a result of the foregoing, Defendants' statements about PEGA's business, operations, prospects, legal compliance, and potential damages exposure in the Appian Litigation were materially false and/or misleading and/or lacked a reasonable basis when made.

The truth regarding PEGA's fraudulent conduct was revealed after the close of the markets on May 9, 2022, when PEGA issued a press release announcing that the jury in the Appian Litigation had awarded Appian more than $2 billion for PEGA's misappropriation of trade secrets. In response to this news, PEGA's stock price fell 21%, from a closing price of $65.93 per share on May 9, 2022, to a closing price of $52.25 on May 10, 2022. As the market continued to digest the verdict, PEGA's stock price dropped another 8% to close at $48.07 per share the following day.

To join the PEGA class action, go to https://rosenlegal.com/submit–form/?case_id=6286 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8572314)

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Oscar Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – OSCR

NEW YORK, June 14, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Oscar Health, Inc. (NYSE: OSCR) pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's March 2021 initial public offering ("IPO" or the "Offering"), of the important July 11, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Oscar securities pursuant and/or traceable to the Registration Statement you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Oscar class action, go to https://rosenlegal.com/submit–form/?case_id=6200 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 11, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the Registration Statement was materially false and misleading and omitted to state that: (1) Oscar was experiencing growing COVID–19 testing and treatment costs; (2) Oscar was experiencing growing net COVID–19 costs; (3) Oscar would be negatively impacted by an unfavorable prior year Risk Adjustment Data Validation (RADV) result relating to 2019 and 2020; (4) Oscar was on track to be negatively impacted by significant Special Enrollment Period (SEP) membership growth; and (5) as a result of the foregoing, defendants' positive statements about Oscar's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Oscar class action, go to https://rosenlegal.com/submit–form/?case_id=6200 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8572313)

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Waste Management, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – WM

NEW YORK, June 14, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Waste Management, Inc. (NYSE: WM) redeemable senior notes (the "Notes") between February 13, 2020 and June 23, 2020, inclusive (the "Class Period"). The Notes include the following senior redeemable notes issued by WM in May 2019: (i) 2.95% Senior Notes due 2024; (ii) 3.20% Senior Notes due 2026; (iii) 3.45% Senior Notes due 2029; and (iv) 4.00% Senior Notes due 2039. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2022.

SO WHAT: If you purchased Waste Management Notes during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Waste Management class action, go to https://rosenlegal.com/submit–form/?case_id=6891 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the DOJ had indicated to Waste Management that it would require Waste Management to divest significantly more assets than the $200 million Antitrust Revenue Threshold; (2) as a result, the merger would not be completed by the End Date; and (3) the Notes would be subject to mandatory redemption at 101% of par.

To join the Waste Management class action, go to https://rosenlegal.com/submit–form/?case_id=6891 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

———————————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8572312)

Reinforcing Success – Fluidic Propulsive System™ Development & New Crowdfunding Initiative

EDMONDS, Wash., June 14, 2022 (GLOBE NEWSWIRE) — Today, Jetoptera announced the launch of their Regulation Crowdfunding raise via StartEngine. We are creating a transformative aerospace propulsion system and capability to evolve vertical takeoff and landing aircraft beyond propellers and rotors.

Jetoptera invites you to be the catalyst, a pioneer, and adventurer with us on this amazing journey to bring forth a safe, quiet multi–use method of propulsion which is focused on S/VTOL, small and medium helicopter replacement with missions spanning logistics, air ambulance, VIP transportation and commonplace aerial mobility, as well as on high–speed VTOL, and wing in ground effect maritime craft, that can scale to a vast array of sizes and applications.

"We are encouraged and enthusiastic about the extensive data we are collecting with the support of the US Air Force to refine the design of our new scalable prototype FPS based vehicles," said Founder and CEO Dr. Andrei Evulet. "Advancements in such a transformational capability as Fluidic Propulsive Systems and their integration into advanced airframe designs demands our attention, focus and determination to make FPS propelled vehicles in the air, land and sea commonplace in the years to come."

To learn more about your Jetoptera Crowdfunded investment opportunity, please go to https://www.startengine.com/jetoptera/

ABOUT JETOPTERA
Jetoptera is a propulsion system, drone, and aerial mobility startup with the vision to create a world where aerial mobility is commonplace. To that end, we have developed and demonstrated a unique Fluidic Propulsive System integrated with a novel airframe, protected by 60 granted and allowed patents and another 100+ pending. This has many advantages over other approaches: faster, simpler, quieter, more compact, and lower cost. Our distributed propulsion system lends itself naturally to our mission, to create vertical and short takeoff and landing (V/STOL) aircraft, with other applications such as wing in ground effect vehicles to enable unmatched speed, range, payload, and efficiency to transport cargo and people.

Contact
Todd Newton
Vice President
+1 (703) 589–3739
info@jetoptera.com

Facebook | LinkedIn


GLOBENEWSWIRE (Distribution ID 8572130)

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Enservco Corporation Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – ENSV

NEW YORK, June 14, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Enservco Corporation (NYSE American: ENSV) between May 13, 2021 and April 18, 2022, both dates inclusive (the "Class Period"), of the important July 19, 2022 lead plaintiff deadline.

SO WHAT: If you purchased Enservco securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Enservco class action, go to https://rosenlegal.com/submit–form/?case_id=6371 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 19, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Enservco had defective disclosure controls and procedures and internal control over financial reporting; (2) as a result, there were errors in Enservco's financial statements relating to, inter alia, its transactions with Cross River Partners and accounting for Employee Retention Credits ("ERCs"); (3) accordingly, Enservco would need to restate certain of its financial statements and delay the filing of its 2021 annual report with the U.S. Securities and Exchange Commission ("SEC"); (4) Enservco downplayed the true scope and severity of its financial reporting issues; (5) accordingly, Enservco could not file its delayed 2021 annual report with the SEC within its initially represented timeline; and (6) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Enservco class action, go to https://rosenlegal.com/submit–form/?case_id=6371 or call Phillip Kim, Esq. toll–free at 866–767–3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the–rosen–law–firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686–1060
Toll Free: (866) 767–3653
Fax: (212) 202–3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com


GLOBENEWSWIRE (Distribution ID 8572063)

Impulse Dynamics Announces First International Implants of the Optimizer Smart Mini System in Italy

MARLTON, N.J., June 14, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a commercial–stage medical device company focused on delivering our CCM therapy to people with heart failure, announced that the first implants in Europe for the newly launched Optimizer Smart Mini device were recently completed in Italy. The company announced the launch of the new technology on April 29, 2022, and the first U.S. implants on May 10, 2022.

Dr. Stefano Guarracini, Head of Cardiology at the Synergo Casa di Cura Pierangeli Hospital in Pescara, Italy, described his experience with CCM therapy and his outlook for the Optimizer Smart Mini system after the first implant. "Starting in 2019, we had the opportunity to implant Optimizer devices in several patients with heart failure. We believe in the technology and consider CCM therapy to be the only option for many patients suffering from heart failure. We are excited now to be affiliated with the first European institution to have implanted the new Optimizer Smart Mini device and look forward to the simple but more advanced patient management experiences during implants and follow–ups going forward."

Dr. Giovani Bisignani, with the Ospedale di Castrovillari, who completed his first implant almost simultaneously in the southern Italian province of Cosenza, said, "CCM therapy is a powerful weapon against heart failure. The cutting–edge technology of the new Optimizer Smart Mini along with its smaller, physiological shape allowed us to achieve efficient implantation and initiation of CCM therapy in even less time."

In March 2022, the company announced that its quality management system received certification under the new European Union Medical Device Regulation. We believe that the launch of the Optimizer Smart Mini system is an example of the importance of a global infrastructure to support ongoing technology innovation and access. The new components of the Optimizer Smart Mini system are equally important across international markets, including a rechargeable battery with a 20–year life and new internal technology with improved programming and potential for remote monitoring in a smaller design to make the implant procedure easier for patients and physicians.

"The pace of this international rollout is a reflection of our commitment to delivering innovation that is relevant to patients worldwide," said Mateusz Zelewski, MD, Impulse Dynamics' Vice President International, "It is exciting to see how quickly we can increase access to new and better technology that offers hope for more patients living with heart failure."

The Optimizer Smart Mini delivers CCM therapy, which consists of electric pulses applied to the heart between heartbeats and serves to enhance the performance of cardiac muscular contraction, making the heart work more efficiently without increasing the heart rate or the oxygen consumption of the cardiac muscle. CCM therapy is currently indicated in Europe to reduce hospitalizations and improve physical exercise tolerance, quality of life, and functional status for a large population of patients with systolic heart failure who remain symptomatic despite guideline–directed medical therapy.

To date, CCM therapy has already been used to treat over 7,000 patients worldwide and is available in 44 countries across the globe. The therapy has been studied in almost 2,000 patients and has appeared in more than 100 peer–reviewed journal articles. Ongoing studies are also underway to examine the safety and efficacy of CCM for patients suffering from heart failure with a left ventricular ejection fraction between 40 "" 60%.

About Impulse Dynamics

Impulse Dynamics is dedicated to helping healthcare providers enhance the lives of people with heart failure by transforming how the condition is treated. The company is focused on delivering its proprietary CCM therapy, which is delivered by the company's Optimizer Smart device, the CE–marked, and FDA–approved treatment verified to improve the quality of life for heart failure patients. CCM therapy is a safe, effective, and minimally invasive treatment option for many heart failure patients who otherwise have few effective options available to them.[1] To learn more, visit www.ImpulseDynamics.com, or follow the company on LinkedIn, Twitter, and Facebook.

Forward–looking Statements

This press release contains forward–looking statements. All statements other than statements of historical facts contained in this press release are forward–looking statements. In some cases, you can identify forward–looking statements by terms such as ""may,'' ""will,'' ""should,'' ""expect,'' ""plan,'' ""anticipate,'' ""could,'' ""intend,'' ""target,'' ""project,'' ""contemplate,'' ""believe,'' ""estimate,'' ""predict,'' ""potential'' or ""continue'' or the negative of these terms or other similar expressions, although not all forward–looking statements contain these words. Forward–looking statements include, but are not limited to, statements concerning potential benefits of CCM therapy, and the absence of risks associated therewith; the ability for CCM therapy and our products to fill a significant unmet medical need for patients with heart failure; and the short–term and long–term benefits of the Optimizer Smart Mini and CCM therapy in patients with heart failure, as well as to the physicians treating those patients. These forward–looking statements are based on management's current expectations and involve known and unknown risks and uncertainties that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward–looking statements. Other important factors that could cause actual results, performance or achievements to differ materially from those contemplated in this press release include, without limitation: the company's future research and development costs, capital requirements and the company's needs for additional financing; commercial success and market acceptance of CCM therapy; the company's ability to achieve and maintain adequate levels of coverage or reimbursement for Optimizer Smart and Optimizer Smart Mini systems or any future products the company may seek to commercialize; competitive companies and technologies in the industry; the company's ability to expand its indications and develop and commercialize additional products and enhancements to its current products; the company's business model and strategic plans for its products, technologies and business, including its implementation thereof; the company's ability to expand, manage and maintain its direct sales and marketing organization; the company's ability to commercialize or obtain regulatory approvals for CCM therapy and its products, or the effect of delays in commercializing or obtaining regulatory approvals; FDA or other U.S. or foreign regulatory actions affecting us or the healthcare industry generally, including healthcare reform measures in the United States and international markets; the timing or likelihood of regulatory filings and approvals; and the company's ability to establish and maintain intellectual property protection for CCM therapy and products or avoid claims of infringement. The company does not undertake any obligation to update forward–looking statements and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward–looking statements contained herein. These forward–looking statements should not be relied upon as representing the company's views as of any date subsequent to the date of this press release.

###

[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494150/

Attachments


GLOBENEWSWIRE (Distribution ID 8571455)